Skip to content
← Back to this collection

PUBLICATIONS · 15205268

Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2004 Oct 15
First author
Ritgen M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Ritgen M
      type
      Author
    2. name
      Stilgenbauer S
      type
      Author
    3. name
      von Neuhoff N
      type
      Author
    4. name
      Humpe A
      type
      Author
    5. name
      Brüggemann M
      type
      Author
    6. name
      Pott C
      type
      Author
    7. name
      Raff T
      type
      Author
    8. name
      Kröber A
      type
      Author
    9. name
      Bunjes D
      type
      Author
    10. name
      Schlenk R
      type
      Author
    11. name
      Schmitz N
      type
      Author
    12. name
      Döhner H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Ritgen M
      type
      Author
    2. name
      Stilgenbauer S
      type
      Author
    3. name
      von Neuhoff N
      type
      Author
    4. name
      Humpe A
      type
      Author
    5. name
      Brüggemann M
      type
      Author
    6. name
      Pott C
      type
      Author
    7. name
      Raff T
      type
      Author
    8. name
      Kröber A
      type
      Author
    9. name
      Bunjes D
      type
      Author
    10. name
      Schlenk R
      type
      Author
    11. name
      Schmitz N
      type
      Author
    12. name
      Döhner H
      type
      Author
    bibliography ids
    1. nci-bib-f8278b4a3524f0214bf65c7e
    book metadata
    content sha256
    02f026cd817d5c05322ea4da3776986224784e17940a4828e0d392978373fb70
    document type
    citation
    dois
    1. 10.1182/blood-2003-12-4321
    electronic publication date
    display
    2004 Jun 17
    precision
    day
    year
    2004
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:15205268
    immutable id
    pubmed:15205268@02f026cd817d5c05322ea4da3776986224784e17940a4828e0d392978373fb70
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    8
    name
    Blood
    nlm unique id
    7603509
    pages
    2600-2
    volume
    104
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      15205268
      provenance
      batch id
      748437a772c9631ad901
      provider
      NCBI PubMed ESummary
      record sha256
      fe3a68f66089abd647f1eb0aa7def6a8717b5c6ede415d2e4cbf2cff15bf93d1
      response sha256
      1535c16de1ca2ef53b01ccf9e7709049035aa1b159955f06fbec3d1a0daddc80
      retrieved at
      2026-09-09T23:45:55.399079+00:00
      publication date
      display
      2004 Oct 15
      precision
      day
      year
      2004
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/15205268/
      title
      Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.

      Preserved source evidence · Not medical advice